Suzanne Louise Bruhn

Companies

• Definium TherapeuticsBoard member Aug 15, 2022 to now¹
• Vigil Neuroscience, Inc.Board member Jul 28, 2022 to now²
• Pliant (United States)Board member Jun 2, 2020 to now³
• Travere Therapeutics, Inc.Board member Apr 9, 2020 to now⁴
• Avalo Therapeutics, Inc.Board member Apr 27, 2020 to Nov 12, 2021⁵
• Aeglea BioTherapeuticsBoard member Feb 16, 2017 to Jun 10, 2020⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• TTTravere Therapeutics, Inc. TVTX32,750 shares⁷$1.7M at $50.55May 19, 2026
• DTDefinium Therapeutics DFTX24,289 shares⁸$833.4K at $34.31Jun 11, 2026
• VNVigil Neuroscience, Inc.0 shares⁹Aug 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 11, 2026Granted 4,666 shares of Definium Therapeutics⁸
• May 19, 2026Granted 4,000 shares of Travere Therapeutics, Inc.⁷
• Aug 5, 2025Returned to company 5,000 shares of Vigil Neuroscience, Inc.⁹
• May 22, 2025Granted 5,000 shares of Vigil Neuroscience, Inc.¹⁰
• May 15, 2025Granted 6,500 shares of Travere Therapeutics, Inc.¹¹
• May 8, 2024Granted 6,500 shares of Travere Therapeutics, Inc.¹²
• Jun 21, 2023Granted 13,671 shares of Definium Therapeutics¹³
• May 17, 2023Granted 4,500 shares of Travere Therapeutics, Inc.¹⁴
• Aug 11, 2022Granted 89,286 shares of Definium Therapeutics¹⁵
• May 11, 2022Granted 3,000 shares of Travere Therapeutics, Inc.¹⁶